Fig. 8From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis A Immunohistochemical staining showing the expression of HSPB1 in situ and in breast cancer metastasis. B The expression of HSPB1 in three triple-negative breast cancer cell lines (MDA-MB-468, MDA-MB-157, and MDA-MB-231) and three other breast cancer cell lines (MCF-7, MDA-MB-453, and BT474) were measured through quantitative real-time PCR (** p < 0.01)Back to article page